Results of chemoradiotherapy for stage I esophageal cancer in medically inoperable patients compared with results in operable patients

Diseases of the Esophagus

Volumn 26, Issue 5, 2013, Pages 522-527

  Jingu, K ^a   Matsushita, H ^a   Takeda, K ^a   Narazaki, K ^a   Ariga, H ^b   Umezawa, R ^a   Sugawara, T ^a   Miyata, G ^a   Onodera, K ^a   Nemoto, K ^c   Yamada, S ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b IWATE MEDICAL UNIVERSITY   (Japan)

^c YAMAGATA UNIVERSITY   (Japan)

Author keywords

Chemoradiotherapy; Medically inoperable; Salvage therapy; Stage I esophageal cancer

Indexed keywords

CISPLATIN; FLUOROURACIL; NEDAPLATIN;

AGED; ARTICLE; CANCER CONTROL; CANCER STAGING; CAUSE SPECIFIC SURVIVAL; CHEMORADIOTHERAPY; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; LOCOREGIONAL CONTROL; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE;

CHEMORADIOTHERAPY; MEDICALLY INOPERABLE; SALVAGE THERAPY; STAGE I ESOPHAGEAL CANCER;

AGE FACTORS; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; CISPLATIN; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; ORGANOPLATINUM COMPOUNDS; SURVIVAL RATE;

EID: 84880327732     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2012.01396.x     Document Type: Article

References (22)

1. Holscher A H, Bollschweiler E, Schneider P M, Siewert J R. Prognosis of early esophageal cancer. Comparison between adeno- and squamous cell carcinoma. Cancer 1995; 76: 178-186.
2. Kato H, Tachimori Y, Watanabe H, Iizuka T. Evaluation of the new (1987) TNM classification for thoracic esophageal tumors. Int J Cancer 1993; 53: 220-223.
3. Lerut T, De Leyn P, Coosemans W, Van Raemdonck D, Scheys I, LeSaffre E. Surgical strategies in esophageal carcinoma with emphasis on radical lymphadenectomy. Ann Surg 1992; 216: 583-590.
4. Ariga H, Nemoto K, Miyazaki S etal. Prospective comparison of surgery alone and chemoradiotherapy with selective surgery in resectable squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 2009; 75: 348-356.
5. Kato H, Sato A, Fukuda H etal. A phase II trial of chemoradiotherapy for stage I esophageal squamous cell carcinoma: Japan Clinical Oncology Group Study (JCOG9708). Jpn J Clin Oncol 2009; 39: 638-643.
6. Herskovic A, Martz K, al-Sarraf M etal. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992; 326: 1593-1598.
7. Ohtsu A, Boku N, Muro K etal. Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus. J Clin Oncol 1999; 17: 2915-2921.
8. Okawa T, Tanaka M, Kita M etal. Radiotherapy for superficial esophageal cancer. Int J Radiat Oncol Biol Phys 1994; 30: 959-964.
9. Crehange G, Peignaux K, Bosset M, Servagi-Vernat S, Bosset J F, Maingon P. Exclusive chemoradiotherapy for patients with medically inoperable early-stage oesophageal cancer. Clin Oncol (R Coll Radiol) 2007; 19: 632-633.
10. Amdal C D, Jacobsen A B, Tausjø J E etal. Radical treatment for oesophageal cancer patients unfit for surgery and chemotherapy. A 10-year experience from the Norwegian Radium Hospital. Acta Oncol 2010; 49: 209-218.
11. Crehange G, Maingon P, Peignaux K etal. Phase III trial of protracted compared with split-course chemoradiation for esophageal carcinoma: Federation Francophone de Cancerologie Digestive 9102. J Clin Oncol 2007; 25: 4895-4901.
12. Uchida N, Takeda Y, Hojo K, Maekawa R, Sugita K, Yoshioka T. Sequence-dependent antitumour efficacy of combination chemotherapy of nedaplatin, a novel platinum complex, with 5-fluorouracil in an in vivo murine tumour model. Eur J Cancer 1998; 34: 1796-1801.
13. Kato H, Tachimori Y, Watanabe H, Yamaguchi H, Ishikawa T, Itabashi M. Superficial esophageal carcinoma. Surgical treatment and the results. Cancer 1990; 66: 2319-2323.
14. Sugimachi K, Watanabe M, Sadanaga N etal. Recent advances in the diagnosis and surgical treatment of patients with carcinoma of the esophagus. J Am Coll Surg 1994; 178: 363-368.
15. Wang G Q, Jiao G G, Chang F B etal. Long-term results of operation for 420 patients with early squamous cell esophageal carcinoma discovered by screening. Ann Thorac Surg 2004; 77: 1740-1744.
16. Ishikawa H, Nonaka T, Sakurai H etal. Usefulness of intraluminal brachytherapy combined with external beam radiation therapy for submucosal esophageal cancer: long-term follow-up results. Int J Radiat Oncol Biol Phys 2010; 76: 452-459.
17. Kodaira T, Fuwa N, Tachibana H etal. Retrospective analysis of definitive radiotherapy for patients with superficial esophageal carcinoma: consideration of the optimal treatment method with a focus on late morbidity. Radiother Oncol 2010; 95: 234-239.
18. Matsumoto S, Takayama T, Tamamoto T etal. A comparison of surgery and radiation therapy for cT1 esophageal squamous cell carcinoma. Dis Esophagus 2011; 24: 411-417.
19. Yamashita H, Okuma K, Seto Y etal. A retrospective comparison of clinical outcomes and quality of life measures between definitive chemoradiation alone and radical surgery for clinical stage II-III esophageal carcinoma. J Surg Oncol 2009; 100: 435-441.
20. Nishimura Y, Okuno Y, Ono K, Mitsumori M, Nagata Y, Hiraoka M. External beam radiation therapy with or without high-dose-rate intraluminal brachytherapy for patients with superficial esophageal carcinoma. Cancer 1999; 86: 220-228.
21. Cooper J S, Guo M D, Herskovic A etal. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 1999; 281: 1623-1627.
22. Nishimura Y, Suzuki M, Nakamatsu K, Kanamori S, Yagyu Y, Shigeoka H. Prospective trial of concurrent chemoradiotherapy with protracted infusion of 5-fluorouracil and cisplatin for T4 esophageal cancer with or without fistula. Int J Radiat Oncol Biol Phys 2002; 53: 134-139.